The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  66 (2024)
Volume  65 (2023)
Volume  64 (2022)
Volume  63 (2021)
Volume  62 (2020)
Volume  61 (2019)
Volume  60 (2018)
Volume  59 (2017)
Volume  58 (2016)
Volume  57 (2015)
Volume  56 (2014)
Volume  55 (2013)
Volume  54 (2012)
Volume  53 (2011)
Volume  52 (2010)
Related articles

VOLUME 53 , ISSUE 1 ( January-March, 2011 ) > List of Articles

EDITORIAL

Nosing Around in Chronic Obstructive Pulmonary Disease

Ashok Shah

Citation Information : Shah A. Nosing Around in Chronic Obstructive Pulmonary Disease. Indian J Chest Dis Allied Sci 2011; 53 (1):5-8.

DOI: 10.5005/ijcdas-53-1-5

License: NA

Published Online: 10-03-2011

Copyright Statement:  NA


Abstract
PDF Share
  1. Laennec RTH. A Treatise on the Diseases of the Chest. New York: Hafner Publishing; 1962.
  2. Briscoe WA, Nash ES. The slow space in chronic obstructive pulmonary diseases. Ann NY Acad Sci 1965;121:706-22.
  3. Beasley R, Weatherall M, Travers J, Shirtcliffe P. Time to define the disorders of the syndrome of COPD. Lancet 2009;374:670-2.
  4. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non smokers. Lancet 2009;374:733-43.
  5. Tran B, Kalhan R. The emerging role of systemic inflammation in chronic obstructive pulmonary disease. Clin Pulm Med 2008;15:55-62.
  6. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007;370:797-9.
  7. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-1504.
  8. Grossman J. One airway one disease. Chest 1997;111:11S- 16S.
  9. Shah A. Rarely does one hear a wheeze without a sneeze [Editorial]. Indian J Chest Dis Allied Sci 2000;42:143-5.
  10. Hurst JR. Upper airway. 3: Sinonasal involvement in chronic obstructive pulmonary disease. Thorax 2010; 65:85-90.
  11. Montnemery P, Svensson C, Adelroth E, Lofdahl CG, Andersson M, Greiff L, et al. Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir J 2001; 17:596-603.
  12. Roberts NJ, Lloyd-Owen SJ, Rapado F, Patel IS, Wilkinson TM, Donaldson GC, et al. Relationship between chronic nasal and respiratory symptoms in patients with COPD. Respir Med 2003;97:909-14.
  13. Hurst JR, Wilkinson TMA, Donaldson GC, Wedzicha JA. Upper airway symptoms and quality of life in chronic obstructive pulmonary disease (COPD). Respir Med 2004; 98:767-70.
  14. Nihlen U, Montnemery P, Andersson M, Persson CG, Nyberg P, Lofdahl CG, et al. Specific nasal symptoms and symptom-provoking factors may predict increased risk of developing COPD. Clin Physiol Funct Imaging 2008;28: 240-50.
  15. Kumar A, Shah A. Occurrence of upper airway symptoms and their impact on quality of life (QoL) in patients with chronic obstructive pulmonary disease (COPD). Respirology 2008;13 (Suppl. 5):A109.
  16. Benninger MS. The impact of cigarette smoking and environmental tobacco smoke on nasal and sinus disease: a review of the literature. Am J Rhinol 1999;13:435-8.
  17. Phillips DE, Hill L, Weller P, Willett M, Bakewell R. Tobacco smoke and the upper airway. Clin Otolaryngol Allied Sci 2003;28:492-6.
  18. Auerbach O, Stout AP, Hammond EC, Garfinkell L. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med 1961;265:253-67.
  19. Bascom R, Kesavanathan J, Fitzgerald TK. Sidestream tobacco smoke exposure acutely alters human nasal mucociliary clearance. Environ Health Perspect 1995; 103:1026-30.
  20. Mahakit P, Pumhiren P. A preliminary study of nasal mucociliary clearance in smokers, sinusitis and allergic rhinitis patients. Asian Pacific J Allergy Immunol 1995; 13:119-21.
  21. Dessi P, Sambuc R, Moulin G, Ledoray V, Cannoni M. Effect of heavy smoking on nasal resistance. Acta Otolaryngol 1994; 114:305-10.
  22. Grieff L, Wollmer P, Andersson M, Persson CG. Human nasal absorption of 51 Cr - EDTA in smokers and control subjects. Clin Exp Allergy 1994;24:1036-40.
  23. Nihlen U, Andersson M, Lofdahl CG, Persson CG, Montnemery P, Greiff L. Nasal neutrophil activity and mucinous secretory responsiveness in COPD. Clin Physiol Funct Imaging 2003;23:138-42.
  24. Hurst JR, Wilkinson TM, Perera WR, Donaldson GC, Wedzicha JA. Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPD. Chest 2005; 127:1219-26.
  25. Hens G, Vanaudenaerde BM, Bullens DMA, Piessens M, Decramer M, Dupont LJ, et al. Sinonasal pathology in nonallergic asthma and COPD: “united airway disease” beyond the scope of allergy. Allergy 2008;63:261-7.
  26. Hurst JR, Perera WR, Wilkinson TM, Donaldson GC, Wedzicha JA. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:71-8.
  27. Hurst JR, Donaldson GC, Wilkinson TMA, Perera WR, Wedzicha JA. Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J 2005;26:846-52.
  28. Piccirillo JF, Merritt MG, Richards ML. Psychometric and clinimetric validity of the 20-item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg 2002;126:41-7.
  29. Jones PW. The St. George's Respiratory Questionnaire. Thorax 1991;46:676-82.
  30. Buckland Jr, Thomas S, Harries PG. Can the Sino-Nasal Outcome Test (SNOT-22) be used as a reliable outcome measure for successful septal surgery? Clin Otolaryngol Allied Sci 2003;28:43-7.
  31. Dewan NA, Rafique S, Kanwar B, Satpathy H, Ryschon K, Tillotson GS, et al. Acute exacerbation of COPD. Factors associated with poor treatment outcome. Chest 2000; 117:662-71.
  32. Kim J-S, Rubin BK. Nasal and sinus inflammation in chronic obstructive pulmonary disease. COPD 2007; 4:163-6.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.